Table 3.
EZH2 post-transcriptional regulation by miR
| MiR | Cancer Type | References |
|---|---|---|
| miR-25, miR-30d | Thyroid cancer | [77] |
| miR-26a | Lymphoma, nasopharyngeal carcinoma, breast cancer, prostate cancer | [78-80] |
| miR-98 | Nasopharyngeal carcinoma, gastric cancer | [81,82] |
| miR-101 | Nasopharyngeal carcinoma, glioblastoma multiform, prostate cancer, bladder cancer, head and neck cancer, non-small cell lung cancer, melanoma | [57,83-88] |
| miR-124 | Hepatocellular carcinoma, gastric cancer | [89,90] |
| miR-137 | Melanoma | [91] |
| miR-138 | Head and neck cancer, glioblastoma multiform, non-small cell lung cancer | [92-94] |
| miR-144 | Bladder cancer | [98] |
| miR-214 | Gastric cancer, hepatocellular carcinoma | [81,95] |
| Let-7 | Prostate cancer, nasopharyngeal carcinoma | [96,97] |